KuartisMED develops biomedical products specifically designed to enhance the care of preterm infants, utilizing precision technologies to monitor and support their health needs. The company addresses critical challenges in neonatal care by providing solutions that improve feeding efficiency and ensure a clean environment for vulnerable newborns.
Funding
$1.8M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
AWFounders
Product
Problem
Preterm infants face significant challenges in feeding and maintaining a sterile environment, which can lead to developmental delays and increased risk of infection. Current methods for monitoring and supporting these infants often lack the precision needed to optimize their care and ensure healthy development.
Solution
KuartisMED develops and provides biomedical products designed to improve the health and well-being of preterm infants. Their products focus on enhancing feeding efficiency and ensuring a clean environment through precision technologies. By addressing these critical needs in neonatal care, KuartisMED aims to support the healthy development of vulnerable newborns and provide peace of mind for their parents. The company's solutions are designed to be user-friendly and effective, integrating seamlessly into existing neonatal care protocols.
Target Audience
The primary target audience includes neonatal intensive care units (NICUs), hospitals, and healthcare providers specializing in the care of preterm infants.
Features
- NeoSAFE: A product focused on improving feeding outcomes for preterm infants.
- Nimie: A product providing precision care to support the healthy development of every baby.
- stetsafe: A product designed to ensure a clean and sterile environment for newborns.